Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1991 1
1993 2
1994 2
1995 2
1996 1
1997 3
1998 6
1999 3
2000 3
2002 2
2003 4
2004 4
2005 2
2006 8
2007 5
2008 14
2009 10
2010 13
2011 10
2012 6
2013 4
2014 8
2015 9
2016 10
2017 4
2018 1
2019 4
2020 2
2021 1
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators. Cannon CP, et al. Among authors: tershakovec am. N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3. N Engl J Med. 2015. PMID: 26039521 Free article. Clinical Trial.
Statin combination therapy and cardiovascular risk reduction.
Toth PP, Farnier M, Tomassini JE, Foody JM, Tershakovec AM. Toth PP, et al. Among authors: tershakovec am. Future Cardiol. 2016 May;12(3):289-315. doi: 10.2217/fca-2015-0011. Epub 2016 Apr 15. Future Cardiol. 2016. PMID: 27079178 Review.
Combination therapy in dyslipidemia: where are we now?
Catapano AL, Farnier M, Foody JM, Toth PP, Tomassini JE, Brudi P, Tershakovec AM. Catapano AL, et al. Among authors: tershakovec am. Atherosclerosis. 2014 Nov;237(1):319-35. doi: 10.1016/j.atherosclerosis.2014.09.026. Epub 2014 Sep 30. Atherosclerosis. 2014. PMID: 25299967 Review.
Medication Discontinuation in the IMPROVE-IT Trial.
Navar AM, Roe MT, White JA, Cannon CP, Lokhnygina Y, Newby LK, Giugliano RP, Tershakovec AM, Braunwald E, Califf RM, Blazing MA. Navar AM, et al. Among authors: tershakovec am. Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e005041. doi: 10.1161/CIRCOUTCOMES.118.005041. Circ Cardiovasc Qual Outcomes. 2019. PMID: 30630361 Free PMC article. Clinical Trial.
Ezetimibe: cholesterol lowering and beyond.
Bays HE, Neff D, Tomassini JE, Tershakovec AM. Bays HE, et al. Among authors: tershakovec am. Expert Rev Cardiovasc Ther. 2008 Apr;6(4):447-70. doi: 10.1586/14779072.6.4.447. Expert Rev Cardiovasc Ther. 2008. PMID: 18402536 Review.
HIV-related lipodystrophy and related factors.
Tershakovec AM, Frank I, Rader D. Tershakovec AM, et al. Atherosclerosis. 2004 May;174(1):1-10. doi: 10.1016/S0021-9150(03)00246-6. Atherosclerosis. 2004. PMID: 15135244 Review.
Letter by Tershakovec et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
Tershakovec AM, Veltri EP, Pasternak RC. Tershakovec AM, et al. Circulation. 2009 Sep 1;120(9):e67; author reply e69-70. doi: 10.1161/CIRCULATIONAHA.109.856666. Circulation. 2009. PMID: 19720943 No abstract available.
135 results